143 related articles for article (PubMed ID: 7920189)
1. Analysis of the mitogenic pathway of the FLT3 receptor and characterization in its C terminal region of a specific binding site for the PI3' kinase.
Casteran N; Rottapel R; Beslu N; Lecocq E; Birnbaum D; Dubreuil P
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):443-56. PubMed ID: 7920189
[TBL] [Abstract][Full Text] [Related]
2. Substrate specificities and identification of a putative binding site for PI3K in the carboxy tail of the murine Flt3 receptor tyrosine kinase.
Rottapel R; Turck CW; Casteran N; Liu X; Birnbaum D; Pawson T; Dubreuil P
Oncogene; 1994 Jun; 9(6):1755-65. PubMed ID: 8183574
[TBL] [Abstract][Full Text] [Related]
3. Fms-like tyrosine kinase 3 catalytic domain can transduce a proliferative signal in FDC-P1 cells that is qualitatively similar to the signal delivered by c-Fms.
Rossner MT; McArthur GA; Allen JD; Metcalf D
Cell Growth Differ; 1994 May; 5(5):549-55. PubMed ID: 8049161
[TBL] [Abstract][Full Text] [Related]
4. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases.
Kubota Y; Angelotti T; Niederfellner G; Herbst R; Ullrich A
Cell Growth Differ; 1998 Mar; 9(3):247-56. PubMed ID: 9543391
[TBL] [Abstract][Full Text] [Related]
5. Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells.
Dosil M; Wang S; Lemischka IR
Mol Cell Biol; 1993 Oct; 13(10):6572-85. PubMed ID: 7692230
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization and analysis of the transforming potential of the FLT3/FLK2 receptor tyrosine kinase.
Maroc N; Rottapel R; Rosnet O; Marchetto S; Lavezzi C; Mannoni P; Birnbaum D; Dubreuil P
Oncogene; 1993 Apr; 8(4):909-18. PubMed ID: 8384358
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic receptors of class III receptor-type tyrosine kinases.
Rosnet O; Birnbaum D
Crit Rev Oncog; 1993; 4(6):595-613. PubMed ID: 7506935
[TBL] [Abstract][Full Text] [Related]
8. p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells.
Zhang S; Broxmeyer HE
Biochem Biophys Res Commun; 1999 Jan; 254(2):440-5. PubMed ID: 9918857
[TBL] [Abstract][Full Text] [Related]
9. Expression of the flt3 receptor and its ligand on hematopoietic cells.
Brasel K; Escobar S; Anderberg R; de Vries P; Gruss HJ; Lyman SD
Leukemia; 1995 Jul; 9(7):1212-8. PubMed ID: 7630197
[TBL] [Abstract][Full Text] [Related]
10. Structure-function analyses of the kit receptor for the steel factor.
Blechman JM; Lev S; Givol D; Yarden Y
Stem Cells; 1993 Jul; 11 Suppl 2():12-21. PubMed ID: 7691317
[TBL] [Abstract][Full Text] [Related]
11. The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.
Lyman SD; Brasel K; Rousseau AM; Williams DE
Stem Cells; 1994; 12 Suppl 1():99-107; discussion 108-10. PubMed ID: 7535149
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol-3' kinase is not required for mitogenesis or internalization of the Flt3/Flk2 receptor tyrosine kinase.
Beslu N; LaRose J; Casteran N; Birnbaum D; Lecocq E; Dubreuil P; Rottapel R
J Biol Chem; 1996 Aug; 271(33):20075-81. PubMed ID: 8702727
[TBL] [Abstract][Full Text] [Related]
13. Bis(1H-2-indolyl)-1-methanones as inhibitors of the hematopoietic tyrosine kinase Flt3.
Teller S; Krämer D; Böhmer SA; Tse KF; Small D; Mahboobi S; Wallrapp C; Beckers T; Kratz-Albers K; Schwäble J; Serve H; Böhmer FD
Leukemia; 2002 Aug; 16(8):1528-34. PubMed ID: 12145694
[TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of a chimeric colony-stimulating factor-1/TrkB-receptor promotes CSF-1-dependent survival of cultured sympathetic neurons.
Erdmann KS; Kaiser AD; Klinz FJ; Zhong J; Krautwald S; Heumann R
Biochem Biophys Res Commun; 1998 Aug; 249(3):891-7. PubMed ID: 9731232
[TBL] [Abstract][Full Text] [Related]
15. Flt3/Flk-2 and c-Kit are not essential for the proliferation of B lymphoid progenitor cells in the bone marrow of the adult mouse.
Ogawa M; Sugawara S; Kunisada T; Sudo T; Hayashi S; Nishikawa S; Kodama H; Nishikawa S
Exp Hematol; 1998 Jun; 26(6):478-88. PubMed ID: 9620281
[TBL] [Abstract][Full Text] [Related]
16. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
[TBL] [Abstract][Full Text] [Related]
17. Mitogenic signals and transforming potential of Nyk, a newly identified neural cell adhesion molecule-related receptor tyrosine kinase.
Ling L; Kung HJ
Mol Cell Biol; 1995 Dec; 15(12):6582-92. PubMed ID: 8524223
[TBL] [Abstract][Full Text] [Related]
18. Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling.
Yu WM; Hawley TS; Hawley RG; Qu CK
Oncogene; 2003 Sep; 22(38):5995-6004. PubMed ID: 12955078
[TBL] [Abstract][Full Text] [Related]
19. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
[TBL] [Abstract][Full Text] [Related]
20. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
